ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,498,373, issued on Dec. 16, was assigned to The Council of the Queensland Institute of Medical Research (Brisbane, Australia).
"Glycoprotein biomarkers for esophageal adenocarcinoma and Barrett's esophagus and uses thereof" was invented by Michelle Mei Chih Hill (Fairfield, Australia), Alok Shah (Fairfield, Australia) and Kim-Ahn Le Cao (Woolloongabba, Australia).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are biomarkers for Barrett's esophagus and esophageal adenocarcinoma, and uses thereof, such as in methods for detecting the presence, and monitoring progression, of Barrett's esophagus and esophageal adenocarcinoma. Also disclosed are met...